Randomized Phase III Study of Erlotinib Versus Observation in Patients With No Evidence of Disease Progression After First-Line Platin-Based Chemotherapy for Ovarian Carcinoma: A European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group, and Gynecologic Cancer Intergroup Study

✍ Scribed by Vergote, I. B.; Jimeno, A.; Joly, F.; Katsaros, D.; Coens, C.; Despierre, E.; Marth, C.; Hall, M.; Steer, C. B.; Colombo, N.; Lesoin, A.; Casado, A.; Reinthaller, A.; Green, J.; Buck, M.; Ray-Coquard, I.; Ferrero, A.; Favier, L.; Reed, N. S.; Cure, H.; Pujade-Lauraine, E.

• Book ID: 127147436
• Publisher: American Society of Clinical Oncology
• Year: 2014
• Tongue: English
• Weight: 189 KB
• Volume: 32
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/jco.2013.50.5669